In today’s recent session, 0.79 million shares of the Guardant Health Inc (NASDAQ:GH) have been traded, and its beta is 1.46. Most recently the company’s share price was $43.67, and it changed around -$0.38 or -0.85% from the last close, which brings the market valuation of the company to $5.41B. GH at last check was trading at a discount to its 52-week high of $52.92, offering almost -21.18% off that amount. The share price’s 52-week low was $18.01, which indicates that the recent value has risen by an impressive 58.76% since then.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.52. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 3 recommended GH as a Hold, whereas 15 deemed it a Buy, and 0 rated it as Underweight. Guardant Health Inc is expected to report earnings per share of -0.54 for the current quarter.
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has been showing red trend so far today with a performance of -0.85% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 52.92 on recent trading dayincreased the stock’s daily price by 17.48%. The company’s shares are currently up 42.96% year-to-date, but still down -11.82% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is 7.63% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $52, which translates to bulls needing to increase their stock price by 16.02% from its current value. Analyst projections state that GH is forecast to be at a low of $52 and a high of $52.
Guardant Health Inc (GH) estimates and forecasts
The year-over-year growth rate is expected to be 19.66%, up from the previous year.
Consensus estimates provided by 19 financial analysts predict the company will bring in an average of 211.42M in revenue for the current quarter. 19 analysts expect Guardant Health Inc to make 226.3M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 177.24M and 191.48M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 19.29%. Forecasts for the next quarter put sales growth at 18.19%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -33.61%. Guardant Health Inc earnings are expected to increase by 22.03% in 2025, but the outlook is positive 19.66% per year for the next five years.
GH Dividends
Guardant Health Inc’s next quarterly earnings report is expected to be released in June.
BLACKROCK INC., with 9.1777% or 11.24 million shares worth $324.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.63 shares worth $158.04 million, making up 2.93% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 3.15 shares worth around $137.03 million, which represents about 2.54% of the total shares outstanding.
